OpenAlex
PricingAboutJobs
Log inGet started
Work

Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies

HTML

Year: 2012
Type: article
Study design: Observational Study
Source: Gut
DOI: 10.1136/gutjnl-2011-301708
Authors: Hsiao-Ping Chen, Jeng-Jer Shieh, Chia-Che Chang, Tzu-Ting Chen, Jaw-Town Lin, Ming-Shiang Wu, Jeng-Horng Lin, Chun-Ying Wu
Institutions: National Chung Hsing University, National Taiwan University Hospital, Taichung Veterans General Hospital, China Medical University, National Health Research Institutes, E-Da Hospital, I-Shou University, National Yang Ming University
Language: English

Topic: Metabolism, Diabetes, and Cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: metformin, hepatocellular carcinoma, chemoprevention, type 2 diabetes, hepatocarcinogenesis, AMPK, LKB1, p21 Cip1, p27, cyclin D1, G0/G1 cell cycle arrest, hepatoma cell proliferation, doxorubicin combination therapy, dose-dependent effects
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2158373383
FWCI: 10.75
Cites: 30
Cited by: 430
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms